Rojina Duwal is a scientist at AstraZeneca since January 2025, previously serving as a research associate at Neogene Therapeutics from January 2022 to December 2024. Rojina's academic journey includes a Master’s degree in Molecular Mechanisms of Disease from Radboud University, completed in 2021, and a Bachelor's degree in Biotechnology from Kathmandu University, obtained in 2017. Rojina has gained substantial research experience through various internships, including projects focused on enhancing intraperitoneal NK cell therapy in ovarian cancer, optimizing chimeric antigen receptor promoters in T cells, and investigating the effects of LDL on monocyte differentiation. Additional research involvement includes an NSF-funded project in collaboration with the Kathmandu Institute of Applied Sciences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices